| Year |
Citation |
Score |
| 2012 |
Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. Journal of Psychopharmacology (Oxford, England). 26: 408-18. PMID 22303032 DOI: 10.1177/0269881111434624 |
0.536 |
|
| 2012 |
Kerwin R. Merck, Sharp & Dohme Prize for Young Psychopharmacologists: A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia. Journal of Psychopharmacology (Oxford, England). 6: 230-40. PMID 22291356 DOI: 10.1177/026988119200600217 |
0.333 |
|
| 2012 |
Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. Journal of Psychopharmacology (Oxford, England). 26: 419-28. PMID 21969106 DOI: 10.1177/0269881111415737 |
0.54 |
|
| 2012 |
Shaikh S, Makoff A, Collier D, Kerwin R. Dopamine D4 Receptors Cns Drugs. 8: 1-11. DOI: 10.2165/00023210-199708010-00001 |
0.424 |
|
| 2010 |
Lynall ME, Bassett DS, Kerwin R, McKenna PJ, Kitzbichler M, Muller U, Bullmore E. Functional connectivity and brain networks in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9477-87. PMID 20631176 DOI: 10.1523/Jneurosci.0333-10.2010 |
0.311 |
|
| 2009 |
Kerwin R. Connecting patient needs with treatment management Acta Psychiatrica Scandinavica. Supplementum. 33-39. PMID 19132965 DOI: 10.1111/J.1600-0447.2008.01312.X |
0.306 |
|
| 2008 |
Silberberg G, Levit A, Collier D, St Clair D, Munro J, Kerwin RW, Tondo L, Floris G, Breen G, Navon R. Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenetics and Genomics. 18: 403-12. PMID 18408563 DOI: 10.1097/Fpc.0B013E3282F974Ca |
0.432 |
|
| 2008 |
Saiz PA, Susce MT, Clark DA, Kerwin RW, Molero P, Arranz MJ, de Leon J. An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects. Human Psychopharmacology. 23: 107-14. PMID 17972277 DOI: 10.1002/Hup.903 |
0.585 |
|
| 2008 |
Compton J, Travis MJ, Norbury R, Erlandsson K, van Amelsvoort T, Daly E, Waddington W, Matthiasson P, Eersels JL, Whitehead M, Kerwin RW, Ell PJ, Murphy DG. Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. Hormones and Behavior. 53: 61-8. PMID 17956758 DOI: 10.1016/J.Yhbeh.2007.08.014 |
0.313 |
|
| 2008 |
Tsapakis E, Sugden K, Kinirons M, Scully P, Quinn J, Wright P, Smith S, Murray R, Daly A, Gill M, Waddington J, Kerwin R, Aitchison K. Association Between Alpha2-Receptor Variants And Movement Disorders Schizophrenia Research. 102: 192. DOI: 10.1016/S0920-9964(08)70582-6 |
0.529 |
|
| 2007 |
Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. European Psychiatry : the Journal of the Association of European Psychiatrists. 22: 433-43. PMID 17555947 DOI: 10.1016/J.Eurpsy.2007.03.002 |
0.326 |
|
| 2007 |
Mancama D, Mata I, Kerwin RW, Arranz MJ. Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 849-53. PMID 17503482 DOI: 10.1002/Ajmg.B.30468 |
0.582 |
|
| 2007 |
Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatric Genetics. 17: 159-63. PMID 17417059 DOI: 10.1097/Ypg.0B013E328017F8A4 |
0.628 |
|
| 2007 |
Clark DA, Mata I, Kerwin RW, Munro J, Arranz MJ. No association between ADRA2A polymorphisms and schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 341-3. PMID 17034020 DOI: 10.1002/Ajmg.B.30355 |
0.626 |
|
| 2007 |
Osborne SA, Munro JC, Stephenson CM, Chaudhry IB, Kerwin RW. Response to clozapine following failure to respond to olanzapine Progress in Neurology and Psychiatry. 11: 9-14. DOI: 10.1002/Pnp.12 |
0.351 |
|
| 2006 |
Kerwin R. Discontinued drugs in 2005: Schizophrenia drugs Expert Opinion On Investigational Drugs. 15: 1487-1495. PMID 17107275 DOI: 10.1517/13543784.15.12.1487 |
0.348 |
|
| 2006 |
Prata DP, Breen G, Munro J, Sinclair M, Osborne S, Li T, Kerwin R, St Clair D, Collier DA. Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics. 16: 229-30. PMID 17106420 DOI: 10.1097/01.Ypg.0000242190.43773.Ce |
0.391 |
|
| 2006 |
Breen G, Prata D, Osborne S, Munro J, Sinclair M, Li T, Staddon S, Dempster D, Sainz R, Arroyo B, Kerwin RW, St Clair D, Collier D. Association of the dysbindin gene with bipolar affective disorder. The American Journal of Psychiatry. 163: 1636-8. PMID 16946192 DOI: 10.1176/Ajp.2006.163.9.1636 |
0.382 |
|
| 2006 |
Lewis SW, Davies L, Jones PB, Barnes TRE, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment Health Technology Assessment. 10: 1-94. PMID 16707074 DOI: 10.3310/Hta10170 |
0.355 |
|
| 2006 |
Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S, Erlandsson K, Eersels J, Kerwin R, Ell P, Travis M. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. The American Journal of Psychiatry. 163: 934-6. PMID 16648340 DOI: 10.1176/Ajp.2006.163.5.934 |
0.323 |
|
| 2006 |
Clark DA, Mancama D, Kerwin RW, Arranz MJ. Expression of the alpha1A-adrenergic receptor in schizophrenia. Neuroscience Letters. 401: 248-51. PMID 16600500 DOI: 10.1016/J.Neulet.2006.03.025 |
0.619 |
|
| 2006 |
Kerwin R, L'Italien G, Hanssens L, Marcus RN, McQuade R, Carson WH, Beuzen JN. P.3.c.028 Effectiveness of aripiprazole versus standard of care treatment in patients with schizophrenia: the Schizophrenia Trial of Aripiprazole (STAR) study European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70515-6 |
0.364 |
|
| 2005 |
Clark DA, Arranz MJ, Mata I, Lopéz-Ilundain J, Pérez-Nievas F, Kerwin RW. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population. Biological Psychiatry. 58: 435-9. PMID 16043131 DOI: 10.1016/J.Biopsych.2005.04.051 |
0.622 |
|
| 2005 |
Surguladze S, Patel A, Kerwin RW, Knapp M, Travis MJ. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 517-22. PMID 15866352 DOI: 10.1016/J.Pnpbp.2005.01.002 |
0.312 |
|
| 2005 |
Bolonna AA, Kerwin RW. Partial agonism and schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 186: 7-10. PMID 15630117 DOI: 10.1192/Bjp.186.1.7 |
0.425 |
|
| 2005 |
Staddon S, Arranz MJ, Mancama D, Perez-Nievas F, Arrizabalaga I, Anney R, Buckland P, Elkin A, Osborne S, Munro J, Mata I, Kerwin RW. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophrenia Research. 73: 49-54. PMID 15567076 DOI: 10.1016/J.Schres.2004.06.011 |
0.64 |
|
| 2005 |
Kerwin R, Osborne S. Pharmacological treatment of schizophrenia Psychiatry. 4: 36-39. DOI: 10.1383/Psyt.2005.4.11.36 |
0.397 |
|
| 2005 |
Kerwin RW, Bolonna A. Management of clozapine-resistant schizophrenia Advances in Psychiatric Treatment. 11: 101-106. DOI: 10.1192/Apt.11.2.101 |
0.343 |
|
| 2005 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.32 Association between the serotonin transporter linked polymorphic region gene and response to tricyclic antidepressants European Neuropsychopharmacology. 15: S26-S27. DOI: 10.1016/S0924-977X(05)80137-3 |
0.569 |
|
| 2004 |
Bolonna AA, Arranz MJ, Mancama D, Kerwin RW. Pharmacogenomics--can genetics help in the care of psychiatric patients? International Review of Psychiatry (Abingdon, England). 16: 311-9. PMID 16194764 DOI: 10.1080/09540260400014369 |
0.591 |
|
| 2004 |
Kerwin RW, Bolonna AA. Is clozapine antisuicidal? Expert Review of Neurotherapeutics. 4: 187-90. PMID 15853559 DOI: 10.1586/14737175.4.2.187 |
0.345 |
|
| 2004 |
Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biological Psychiatry. 56: 406-10. PMID 15364038 DOI: 10.1016/J.Biopsych.2004.06.020 |
0.553 |
|
| 2004 |
Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatrica Scandinavica. 110: 292-8. PMID 15352931 DOI: 10.1111/J.1600-0447.2004.00356.X |
0.324 |
|
| 2004 |
Kerwin RW, Osborne S, Sainz-Fuertes R. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. Journal of Psychopharmacology (Oxford, England). 18: 121-3. PMID 15107195 DOI: 10.1177/0269881104040250 |
0.304 |
|
| 2004 |
Huezo-Diaz P, Arranz MJ, Munro J, Osborne S, Makoff A, Kerwin RW, Austin J, O'Donovan M. An association study of the neurotensin receptor gene with schizophrenia and clozapine response. Schizophrenia Research. 66: 193-5. PMID 15061255 DOI: 10.1016/S0920-9964(03)00128-2 |
0.639 |
|
| 2004 |
Mata I, Arranz MJ, Patiño A, Lai T, Beperet M, Sierrasesumaga L, Clark D, Perez-Nievas F, Richards L, Ortuño F, Sham P, Kerwin RW. Serotonergic polymorphisms and psychotic disorders in populations from North Spain. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 126: 88-94. PMID 15048655 DOI: 10.1002/Ajmg.B.20150 |
0.597 |
|
| 2004 |
Mancama D, Arranz M, Staddon S, Parsons M, Clark D, Osborne S, Munro J, Kerwin R. S.4.07 Applications of pharmacogenetics and pharmacogenomics in the improvement of psychiatric treatment European Neuropsychopharmacology. 14: S68. DOI: 10.1016/S0924-977X(04)90085-5 |
0.493 |
|
| 2004 |
Clark D, Staddon S, Mata I, Mancama D, Arranz M, Kerwin R. S.4.02 Dopamine 3 (D3) receptors genetic variants: influence in schizophrenia and antipsychotic response European Neuropsychopharmacology. 14: S64-S65. DOI: 10.1016/S0924-977X(04)90080-6 |
0.623 |
|
| 2004 |
Parsons M, Mancama D, Arranz M, Kerwin R. P.1.07 Gene expression profiling to identify new targets associated with schizophrenia and its treatment European Neuropsychopharmacology. 14: S7-S8. DOI: 10.1016/S0924-977X(04)90008-9 |
0.581 |
|
| 2003 |
Mancama D, Arranz MJ, Kerwin RW. Pharmacogenomics of psychiatric drug treatment. Current Opinion in Molecular Therapeutics. 5: 642-9. PMID 14755891 |
0.494 |
|
| 2003 |
Arranz MJ, Kerwin RW. Advances in the pharmacogenetic prediction of antipsychotic response. Toxicology. 192: 33-5. PMID 14511901 DOI: 10.1016/S0300-483X(03)00248-8 |
0.57 |
|
| 2003 |
Duggan A, Warner J, Knapp M, Kerwin R. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. The British Journal of Psychiatry : the Journal of Mental Science. 182: 505-8. PMID 12777341 DOI: 10.1192/Bjp.182.6.505 |
0.325 |
|
| 2003 |
Mancama D, Arranz MJ, Landau S, Kerwin R. Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 2-6. PMID 12707929 DOI: 10.1002/Ajmg.B.20020 |
0.627 |
|
| 2003 |
Mancama D, Kerwin RW. Role of pharmacogenomics in individualising treatment with SSRIs. Cns Drugs. 17: 143-51. PMID 12617694 DOI: 10.2165/00023210-200317030-00001 |
0.333 |
|
| 2003 |
Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV, Bolonna A, Kerwin RW, Arranz MJ, Makoff AJ, Kennedy JL. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Molecular Psychiatry. 8: 241-5. PMID 12610658 DOI: 10.1038/Sj.Mp.4001218 |
0.553 |
|
| 2003 |
Kerwin R. Clozapine and prevention of suicide in schizophrenia a viewpoint by Robert Kerwin Cns Drugs. 17: 282-283. DOI: 10.2165/00023210-200317040-00007 |
0.341 |
|
| 2003 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.178 Association between the serotonin transporter linked polymorphic region gene (5-HTTLPR) and response to tricyclic antidepressants (TCAs) European Neuropsychopharmacology. 13: S250. DOI: 10.1016/S0924-977X(03)91888-8 |
0.569 |
|
| 2003 |
Parsons MJ, Makoff A, D'Souza U, Arranz MJ, Kerwin R. The-1438-A/G serotonin 2A receptor promoter polymorphism affects promoter activity Schizophrenia Research. 60: 96-96. DOI: 10.1016/S0920-9964(03)80672-2 |
0.329 |
|
| 2003 |
Staddon S, Arranz M, Buckland P, Osborne S, Mata I, Kerwin R. Polymorphisms in the dopamine D3 receptor gene and improvement in positive symptoms of schizophrenia Schizophrenia Research. 60: 90-91. DOI: 10.1016/S0920-9964(03)80656-4 |
0.619 |
|
| 2003 |
Mancama DT, Mata I, Munro J, Osborne S, Arranz M, Kerwin R. Analysis of muscarinic 1 promoter polymorphisms on receptor expression and outcome to atypical antipsychotic treatment Schizophrenia Research. 60: 85-85. DOI: 10.1016/S0920-9964(03)80639-4 |
0.581 |
|
| 2003 |
Lai T, Mancama D, Mata I, Arrondo J, Munro J, Arranz MJ, Kerwin R. The serotonin 5HT2C-244(CT) repeat polymorphism does not influence susceptibility to schizophrenia or outcome to olanzapine treatment Schizophrenia Research. 60: 84. DOI: 10.1016/S0920-9964(03)80636-9 |
0.379 |
|
| 2003 |
Clark D, Eva R, Mata I, Arranz M, Kerwin R. Association analysis of polymorphism (ARG492CYS) in the α1A-adrenergic receptor gene with schizophrenia and antipsychotic treatment Schizophrenia Research. 60: 79-80. DOI: 10.1016/S0920-9964(03)80622-9 |
0.645 |
|
| 2003 |
Arroyo B, Parsons M, Arranz M, Arrondo J, Beperet M, Mata I, Kerwin R. Association of a D2 receptor gene polymorphism and schizophrenia in the spanish population Schizophrenia Research. 60: 78. DOI: 10.1016/S0920-9964(03)80616-3 |
0.443 |
|
| 2003 |
Arranz M, Clark D, Mancama D, Parsons M, Staddon S, Beperet M, Arrondo J, Mata I, Kerwin R. Clinical applications of pharmacogenetics: Pre-treatment prediction of antipsychotic response Schizophrenia Research. 60: 77. DOI: 10.1016/S0920-9964(03)80615-1 |
0.528 |
|
| 2003 |
Surguladze S, Patel A, Kerwin R, Knapp M, Travis M. Preliminary cost analysis of treating schizophrenia with amisulpride: an ongoing naturalistic mirror image study Schizophrenia Research. 60: 345-346. DOI: 10.1016/S0920-9964(03)80352-3 |
0.327 |
|
| 2003 |
Mancama D, Arranz MJ, Kerwin RW. Genetic perspectives of histamine and muscarinic receptors in schizophrenia and clozapine response Drug Development Research. 60: 119-126. DOI: 10.1002/Ddr.10291 |
0.613 |
|
| 2003 |
Arranz MJ, Kerwin RW. Pharmacogenetic and pharmacogenomic research for the prediction of response to antipsychotics in schizophrenia Drug Development Research. 60: 104-110. DOI: 10.1002/Ddr.10289 |
0.605 |
|
| 2002 |
Mancama D, Arranz MJ, Munro J, Osborne S, Makoff A, Collier D, Kerwin R. Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neuroscience Letters. 333: 207-11. PMID 12429384 DOI: 10.1016/S0304-3940(02)00178-7 |
0.604 |
|
| 2002 |
Arias B, Arranz MJ, Gasto C, Catalan R, Pintor L, Gutierrez B, Kerwin RW, Fananas L. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Molecular Psychiatry. 7: 930-2. PMID 12399944 DOI: 10.1038/Sj.Mp.4001146 |
0.554 |
|
| 2002 |
Shaikh S, Kerwin RW. Receptor pharmacogenetics: relevance to CNS syndromes. British Journal of Clinical Pharmacology. 54: 344-8. PMID 12392580 DOI: 10.1046/J.1365-2125.2002.01679.X |
0.33 |
|
| 2002 |
Kuperberg G, Kerwin R, Murray R. Developments in the pharmacological treatment of schizophrenia Expert Opinion On Investigational Drugs. 11: 1335-1341. PMID 12387698 DOI: 10.1517/13543784.11.10.1335 |
0.369 |
|
| 2002 |
Mata-Pastor I, Arranz-Calderón MJ, Beperet-Urmeneta M, Pérez-Nievas F, Sham P, Kerwin R. Influence of serotonergic transmission on response to olanzapine | Influencia de la transmisión serotoninérgica en la respuesta a olanzapina Actas Espanolas De Psiquiatria. 30: 265-271. PMID 12372221 |
0.341 |
|
| 2002 |
Gutiérrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, Munro J, Osborne S, Kerwin RW. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophrenia Research. 58: 93-7. PMID 12363396 DOI: 10.1016/S0920-9964(02)00205-0 |
0.624 |
|
| 2002 |
East SZ, Burnet PW, Kerwin RW, Harrison PJ. An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophrenia Research. 57: 15-26. PMID 12165372 DOI: 10.1016/S0920-9964(01)00323-1 |
0.49 |
|
| 2002 |
Staddon S, Arranz MJ, Mancama D, Mata I, Kerwin RW. Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology. 162: 18-23. PMID 12107612 DOI: 10.1007/S00213-002-1084-4 |
0.562 |
|
| 2002 |
Ilia M, Beasley C, Meijer D, Kerwin R, Cotter D, Everall I, Price J. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia American Journal of Psychiatry. 159: 1174-1182. PMID 12091196 DOI: 10.1176/Appi.Ajp.159.7.1174 |
0.302 |
|
| 2002 |
Mancama D, Arranz MJ, Kerwin RW. Genetic predictors of therapeutic response to clozapine: current status of research. Cns Drugs. 16: 317-24. PMID 11994021 DOI: 10.2165/00023210-200216050-00004 |
0.585 |
|
| 2002 |
Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry. 73: 1590-1597. PMID 10501205 DOI: 10.1046/J.1471-4159.1999.0731590.X |
0.34 |
|
| 2002 |
Tandon K, Schalkwyk L, Patel M, Kinirons M, Kerwin R, McGuffin P, Aitchison K. An amino acid substitution (Ile109Val) in CYP2D6 European Neuropsychopharmacology. 12: 405. DOI: 10.1016/S0924-977X(02)80692-7 |
0.465 |
|
| 2002 |
Aitchison K, Tandon K, Ashworth A, Kerwin R, McGuffin P. Pharmacogenetic studies of tricyclic antidepressant response and an association study of a noradrenaline transporter variant in depression European Neuropsychopharmacology. 12: 92-93. DOI: 10.1016/S0924-977X(02)80022-0 |
0.511 |
|
| 2001 |
Arranz MJ, Collier D, Kerwin RW. Pharmacogenetics for the individualization of psychiatric treatment. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 1: 3-10. PMID 12173312 DOI: 10.2165/00129785-200101010-00001 |
0.576 |
|
| 2001 |
Kerwin RW, Mancama DT, Arranz MJ. Genetic strategies for the personalization of antipsychotic treatment. Expert Review of Molecular Diagnostics. 1: 275-80. PMID 11901832 DOI: 10.1586/14737159.1.3.275 |
0.583 |
|
| 2001 |
Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Molecular Psychiatry. 6: 373-9. PMID 11443520 DOI: 10.1038/Sj.Mp.4000920 |
0.647 |
|
| 2001 |
Arranz MJ, Munro J, Osborne S, Collier D, Kerwin RW. Applications of pharmacogenetics in psychiatry: personalisation of treatment. Expert Opinion On Pharmacotherapy. 2: 537-42. PMID 11336604 DOI: 10.1517/14656566.2.4.537 |
0.587 |
|
| 2001 |
Bolonna AA, Kerwin RW, Munro J, Arranz MJ, Makoff AJ. Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophrenia Research. 47: 99-103. PMID 11163549 DOI: 10.1016/S0920-9964(99)00235-2 |
0.61 |
|
| 2001 |
Arranz MJ, Mancama D, Kerwin RW. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)). International Journal of Molecular Medicine. 7: 27-30. PMID 11115604 DOI: 10.3892/Ijmm.7.1.27 |
0.569 |
|
| 2001 |
Kerwin R. Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue. Bmj. 322: 926-926. DOI: 10.1136/Bmj.322.7291.924/A |
0.333 |
|
| 2001 |
Collier DA, Osborne S, Munro J, Kerwin RW. Pharmacogenetic methods in schizophrenia International Review of Psychiatry. 13: 47-49. DOI: 10.1080/09540260020024196 |
0.345 |
|
| 2001 |
Kerwin R. It's a SNP – a loose-leaf bible for bioentrepreneurs Trends in Pharmacological Sciences. 22: 209. DOI: 10.1016/S0165-6147(00)01657-6 |
0.302 |
|
| 2001 |
Staddon SL, Mata I, Osborne S, Munro J, Huezo-Diaz P, Arranz MJ, Kerwin RW. An association study of the 5-HT6 267-C/T polymorphism and antipsychotic response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 619. |
0.506 |
|
| 2001 |
Mancama DT, Preece P, Landau S, Arranz MJ, Kerwin RW. Relative quantification analysis of cortical histamine 1 and muscarinic 1 receptor expression in patients with schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 623. |
0.555 |
|
| 2001 |
Staddon LS, Mata I Osborne S, Munro J, Huezo-Diaz P, Arranz MJ, Kerwin RW. An association study of the 5-HT6 267-C/T variant and antipsychotic response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641-642. |
0.489 |
|
| 2001 |
Staddon SL, Arranz MJ, Mata I, Mathiasson P, Richards L, Arroyo B, Kerwin RW. An association study of a D3 polymorphism and olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641. |
0.503 |
|
| 2001 |
Lai T, Arranz MJ, Mata I, Beperet M, Collier D, Matthiasson P, Kerwin RW. Investigation of 5-HT2C polymorphisms and their influence on olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641. |
0.513 |
|
| 2001 |
Dempster D, Mancama D, Gutierrez B, Mata I, Beperet M, Arranz MJ, Kerwin RW. An association study of 5-HT5A and 5-HT3B polymorphisms and olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 641. |
0.524 |
|
| 2001 |
Arranz MJ, Staddon S, Mata I, Beperet M, Munro J, Osborne S, Kerwin RW. Genetic predictors of olanzapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 581. |
0.463 |
|
| 2001 |
Mundo E, Tharmalingham S, Dalton J, Bolonna A, Arranz MJ, Kerwin RW, Kennedy JL. The N-Methyl-D-Aspartate receptor subunit 1 gene (GRIN1) and rapid cycling course in Bipolar Disorder American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 621. |
0.487 |
|
| 2001 |
Aitchison KJ, Zhao JH, Munro J, Collier DA, Makoff AJ, Kerwin RW. Investigation of an association between a CYP1A2 5′ flanking SNP (T-3591G) and response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 582. |
0.487 |
|
| 2001 |
Parsons MJ, D'Souza U, Makoff A, Arranz MJ, Kerwin R. Effects of the -1438-A/G serotonin 2A receptor promotor polymorphism on expression American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 584. |
0.506 |
|
| 2000 |
Taylor D, Mace S, Mir S, Kerwin R. A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom. International Journal of Psychiatry in Clinical Practice. 4: 41-46. PMID 24927311 DOI: 10.1080/13651500052048749 |
0.334 |
|
| 2000 |
Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. Journal of Psychopharmacology (Oxford, England). 14: 353-9. PMID 11198052 DOI: 10.1177/026988110001400403 |
0.491 |
|
| 2000 |
Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics. 10: 695-704. PMID 11186132 DOI: 10.1097/00008571-200011000-00004 |
0.521 |
|
| 2000 |
Bell R, Munro J, Russ C, Powell JF, Bruinvels A, Kerwin RW, Collier DA. Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia. American Journal of Medical Genetics. 96: 736-43. PMID 11121172 DOI: 10.1002/1096-8628(20001204)96:6<736::Aid-Ajmg8>3.0.Co;2-2 |
0.398 |
|
| 2000 |
Arranz MJ, Munro J, Osborne S, Collier D, Kerwin RW. Difficulties in replication of results. Lancet. 356: 1359-60. PMID 11073057 DOI: 10.1016/S0140-6736(05)74275-6 |
0.45 |
|
| 2000 |
Stephenson CM, Bigliani V, Jones HM, Mulligan RS, Acton PD, Visvikis D, Ell PJ, Kerwin RW, Pilowsky LS. Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study. The British Journal of Psychiatry : the Journal of Mental Science. 177: 408-15. PMID 11059993 DOI: 10.1192/Bjp.177.5.408 |
0.306 |
|
| 2000 |
Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study. Psychopharmacology. 150: 132-40. PMID 10907666 DOI: 10.1007/S002130000435 |
0.352 |
|
| 2000 |
Birkett JT, Arranz MJ, Munro J, Osbourn S, Kerwin RW, Collier DA. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. 11: 2017-20. PMID 10884063 DOI: 10.1097/00001756-200006260-00042 |
0.625 |
|
| 2000 |
Arranz MJ, Bolonna AA, Munro J, Curtis CJ, Collier DA, Kerwin RW. The serotonin transporter and clozapine response. Molecular Psychiatry. 5: 124-5. PMID 10822334 DOI: 10.1038/Sj.Mp.4000652 |
0.519 |
|
| 2000 |
Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch KP, Meyer JF, Sham P, Collier DA, Murray RM, Kerwin RW. Pharmacogenetic prediction of clozapine response. Lancet. 355: 1615-6. PMID 10821369 DOI: 10.1016/S0140-6736(00)02221-2 |
0.702 |
|
| 2000 |
Arranz MJ, Kerwin RW. Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment. Annals of Medicine. 32: 128-33. PMID 10766404 DOI: 10.3109/07853890009011762 |
0.594 |
|
| 2000 |
Bolonna AA, Arranz MJ, Munro J, Osborne S, Petouni M, Martinez M, Kerwin RW. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response. Neuroscience Letters. 280: 65-8. PMID 10696813 DOI: 10.1016/S0304-3940(99)01000-9 |
0.644 |
|
| 2000 |
Jones HM, Travis MJ, Mulligan R, Visvikis D, Gacinovic S, Ell PJ, Kerwin RW, Pilowsky LS. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine. The American Journal of Psychiatry. 157: 148. PMID 10618043 DOI: 10.1176/Ajp.157.1.148 |
0.304 |
|
| 2000 |
Taylor DM, Mir S, Kerwin R. Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol Psychiatric Bulletin. 24: 106-108. DOI: 10.1192/Pb.24.3.106 |
0.328 |
|
| 2000 |
Mancama D, Arranz M, Munro J, Makoff A, Kerwin R. The histamine 1 and histamine 2 receptor genes - candidates for schizophrenia and clozapine drug response Genescreen. 1: 29-34. DOI: 10.1046/J.1466-9218.2000.00005.X |
0.648 |
|
| 2000 |
Sodhi M, Makoff A, Crossland N, Kerwin R, Harrison P. RNA editing of the 5-HT2C receptor in human brain Schizophrenia Research. 41: 253. DOI: 10.1016/S0920-9964(00)90939-3 |
0.408 |
|
| 2000 |
Jones HM, Travis MJ, Mulligan R, Bressan R, Visvikis D, Gacinovic S, Ell PJ, Kerwin RW, Pilowsky LS. Serotonin, 5-HT2A receptor occupancy in vivo and response to the new atypical antipsychotic quetiapine Schizophrenia Research. 41: 245. DOI: 10.1016/S0920-9964(00)90918-6 |
0.402 |
|
| 2000 |
Mancama D, Munro J, Arranz M, Makoff A, Kerwin R. Novel polymorphisms in the histamine 1 and 2 receptor genes, schizophrenia and clozapine drug response Schizophrenia Research. 41: 242. DOI: 10.1016/S0920-9964(00)90909-5 |
0.646 |
|
| 2000 |
Bressan RA, Bigliani VB, Mulligan RS, Stephenson C, Costa DC, Jones HM, Ell PJ, Kerwin RW, Pilowsky LS. Striatal D2 blockade and depression in schizophrenia — preliminary spet findings Schizophrenia Research. 41: 238-238. DOI: 10.1016/S0920-9964(00)90898-3 |
0.34 |
|
| 2000 |
Aitchison K, Jann M, Wolff K, Sakai T, Makoff A, Collier D, Gonzalez F, Kerwin R. Clozapine pharmacokinetics studied with CYP1A2 knockout mice Schizophrenia Research. 41: 235. DOI: 10.1016/S0920-9964(00)90889-2 |
0.482 |
|
| 2000 |
Lewis SW, Davies L, Jones P, Kerwin R, Barnes TRE, Murray RM, Esmail A, Knapp M, Marshall M, Taylor D, Dunn G, Gervin M, Hynes F, Blackwell C, Markwick A, et al. The cutlass study: A pragmatic, multicentre trial of the effectiveness and costs of atypical antipsychotic drugs in schizophrenia Schizophrenia Research. 41: 214. DOI: 10.1016/S0920-9964(00)90833-8 |
0.356 |
|
| 2000 |
Beasley CL, Cotter D, Kerwin R, Khan N, Everall IP. Glycogen synthase kinase 3β in the hippocampus in schizophrenia Schizophrenia Research. 41: 109. DOI: 10.1016/S0920-9964(00)90560-7 |
0.31 |
|
| 2000 |
Cotter D, Stevenson RL, Kerwin R, Beasley CL, Everall IP. No alterations in the density of parvalbumin or calretinin immunoreactive neurons in the anterior cingulate cortex (BA 24b/c) in schizophrenia or bipolar disorder Schizophrenia Research. 41: 107-108. DOI: 10.1016/S0920-9964(00)90557-7 |
0.31 |
|
| 2000 |
Cotter D, Beasley CL, Kerwin R, Everall IP. The spatial pattern of parvalbumin immuno-reactive neurons in the anterior cingulate cortex (BA 24b/c) in schizophrenia and bipolar disorder Schizophrenia Research. 41: 107. DOI: 10.1016/S0920-9964(00)90556-5 |
0.304 |
|
| 2000 |
Arranz M, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch K, Meyer J, Sham P, Collier D, Murray R, Kerwin R. Individualisation of treatment: Genetic prediction of clozapine response Schizophrenia Research. 41: 97. DOI: 10.1016/S0920-9964(00)90535-8 |
0.653 |
|
| 2000 |
Gutiérrez B, Arranz M, Munro J, Osborne S, Murray R, Fañanás L, Kerwin R. Positive association between a novel dinucleotide repeat polymorphism in the human serotonin-3B receptor gene (5HT3B) and clinical response to clozapine Schizophrenia Research. 41: 97. DOI: 10.1016/S0920-9964(00)90534-6 |
0.395 |
|
| 2000 |
Jones H, Travis M, Mulligan R, Bressan R, Visvikis D, Gacinovic S, Ell P, Kerwin R, Pilowsky L. 58. 5-HT2A receptor blockade by quetiapine is related to its side effect profile Biological Psychiatry. 47: S18. DOI: 10.1016/S0006-3223(00)00320-6 |
0.342 |
|
| 2000 |
Arranz MJ, Munro J, Osborne S, Gutierrez B, Huezo P, Dempster D, Hassan BA, Niesler B, Rappold G, Kerwin RW. Novel polymorphisms in 5-HT3A receptor gene not related to schizophrenia and clozapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 538. |
0.606 |
|
| 2000 |
Huezo P, Arranz MJ, Munro J, Osborne S, Austin J, O'Donovan MC, Kerwin RW. Association studies of two neurotensin receptor gene polymorphisms with schizophrenia and clozapine response American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 539. |
0.609 |
|
| 2000 |
Arranz MJ, Mancama D, Munro J, Osborne S, Travis M, Matthiasson P, Madoz V, Perez-Nievas F, Mata I, Kerwin RW. Influence of polymorphisms in serotonin receptors on response to atypical antipsychotics American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 466-467. |
0.584 |
|
| 2000 |
Basile VS, Masellis M, Ozdemir V, Quiterio S, Meltzer HY, Lieberman JA, Mancama D, Arranz MJ, Kerwin RW, Kennedy JL. Novel histamine H1 gene polymorphism and clozapine-induced weight gain American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 538-539. |
0.472 |
|
| 1999 |
Bigliani V, Mulligan RS, Acton PD, Visvikis D, Ell PJ, Stephenson C, Kerwin RW, Pilowsky LS. In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study. The British Journal of Psychiatry : the Journal of Mental Science. 175: 231-8. PMID 10645324 DOI: 10.1192/Bjp.175.3.231 |
0.364 |
|
| 1999 |
Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology. 48: 388-94. PMID 10510151 DOI: 10.1046/J.1365-2125.1999.00006.X |
0.557 |
|
| 1999 |
Kerwin R, Owen M. Genetics of novel therapeutic targets in schizophrenia British Journal of Psychiatry. 174: 1-4. DOI: 10.1192/S000712500029805X |
0.36 |
|
| 1998 |
Travis MJ, Busatto GF, Pilowsky LS, Mulligan R, Acton PD, Gacinovic S, Mertens J, Terrière D, Costa DC, Ell PJ, Kerwin RW. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. The British Journal of Psychiatry : the Journal of Mental Science. 173: 236-41. PMID 9926100 DOI: 10.1192/Bjp.173.3.236 |
0.405 |
|
| 1998 |
Arranz MJ, Li T, Munro J, Liu X, Murray R, Collier DA, Kerwin RW. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Pharmacogenetics. 8: 481-4. PMID 9918131 DOI: 10.1097/00008571-199812000-00004 |
0.654 |
|
| 1998 |
Arranz MJ, Munro J, Sham P, Kirov G, Murray RM, Collier DA, Kerwin RW. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research. 32: 93-9. PMID 9713904 DOI: 10.1016/S0920-9964(98)00032-2 |
0.627 |
|
| 1998 |
Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 32: 87-92. PMID 9713903 DOI: 10.1016/S0920-9964(98)00024-3 |
0.709 |
|
| 1998 |
Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Molecular Psychiatry. 3: 61-6. PMID 9491814 DOI: 10.1038/Sj.Mp.4000348 |
0.577 |
|
| 1998 |
Stefanis NC, Bresnick JN, Kerwin RW, Schofield WN, McAllister G. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Brain Research. Molecular Brain Research. 53: 112-9. PMID 9473618 DOI: 10.1016/S0169-328X(97)00285-4 |
0.376 |
|
| 1998 |
Travis M, Busatto G, Pilowsky L, Mulligan R, Gacinovic S, Acton P, Costa D, Mertens J, Terrière D, Ell P, Kerwin R. Typical antipsychotics lead to 5-HT2A receptor blockade In vivo in schizophrenic patients: Initial single photon emission tomography (SPET) findings Schizophrenia Research. 29: 171. DOI: 10.1016/S0920-9964(97)88743-9 |
0.325 |
|
| 1998 |
Bigliani V, Mulligan RS, Acton PDZ, Gacinovic S, Ell PJZ, Kerwin RW, Pilowsky LS. Different patterns of D2/D2-like receptor blockade in the temporal cortex and the striatum by typical antipsychotics: An 123I-epidepride spet study Schizophrenia Research. 29: 165. DOI: 10.1016/S0920-9964(97)88727-0 |
0.317 |
|
| 1998 |
Birkett J, Collier D, Kerwin R. A second novel polymorphism in the promotor region of the N-acetyltransferase gene (AA-NAT) is not associated with schizophrenia or bipolar affective disorder Schizophrenia Research. 29: 130-131. DOI: 10.1016/S0920-9964(97)88629-X |
0.4 |
|
| 1998 |
Bolonna A, Makoff A, Collier D, Arranz M, Kerwin R. The NMDAR1 receptor gene and schizophrenia Schizophrenia Research. 29: 130. DOI: 10.1016/S0920-9964(97)88627-6 |
0.437 |
|
| 1998 |
Arranz M, Munro J, Collier D, Kirov G, Kerwin R. Genetic variation in the 5-HT3 receptor gene: No association with schizophrenia or drug response Schizophrenia Research. 29: 127-128. DOI: 10.1016/S0920-9964(97)88620-3 |
0.45 |
|
| 1998 |
Arranz M, Munro J, Li T, Collier D, Kirov G, Kerwin R. A polymorphism in the promoter region of the dopamine D2 receptor gene (DRD2) and drug response: Association studies Schizophrenia Research. 29: 127. DOI: 10.1016/S0920-9964(97)88619-7 |
0.412 |
|
| 1998 |
Arranz M, Munro J, Collier D, Krov G, Sham P, Zhao J, Kerwin R. Further evidence for association between polymorphisms in the 5-HT2A receptor gene and clozapine response Schizophrenia Research. 29: 127. DOI: 10.1016/S0920-9964(97)88618-5 |
0.43 |
|
| 1998 |
Cotter D, Roberts E, Kerwin R, Doshi B, Everall I. Increased hippocampal dendritic expression of non-phosphorylated MAP2 protein in schizophrenia Schizophrenia Research. 29: 89-90. DOI: 10.1016/S0920-9964(97)88524-6 |
0.303 |
|
| 1997 |
Kerwin RW, Aitchison KJ. Cost-effectiveness of clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 171: 584. PMID 9519106 |
0.423 |
|
| 1997 |
Busatto GF, Kerwin RW. Schizophrenia, psychosis, and the basal ganglia. The Psychiatric Clinics of North America. 20: 897-910. PMID 9443356 DOI: 10.1016/S0193-953X(05)70351-8 |
0.37 |
|
| 1997 |
Bell R, Collier DA, Rice SQ, Roberts GW, MacPhee CH, Kerwin RW, Price J, Gloger IS. Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia. Biochemical and Biophysical Research Communications. 241: 630-5. PMID 9434759 DOI: 10.1006/Bbrc.1997.7741 |
0.417 |
|
| 1997 |
Travis MJ, Busatto GF, Pilowsky LS, Kerwin RW, Mulligan R, Gacinovic S, Costa DC, Ell PJ, Mertens J, Terriere D. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole. The British Journal of Psychiatry : the Journal of Mental Science. 171: 290-1. PMID 9337994 DOI: 10.1192/Bjp.171.3.290C |
0.402 |
|
| 1997 |
Aitchison KJ, Kerwin RW. Cost-effectiveness of clozapine. A UK clinic-based study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 125-30. PMID 9337946 DOI: 10.1192/Bjp.171.2.125 |
0.476 |
|
| 1997 |
Pilowsky LS, O'Connell P, Davies N, Busatto GF, Costa DC, Murray RM, Ell PJ, Kerwin RW. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study. Psychopharmacology. 130: 152-8. PMID 9106913 DOI: 10.1007/S002130050223 |
0.347 |
|
| 1997 |
Busatto GF, Kerwin RW. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. Journal of Psychopharmacology (Oxford, England). 11: 3-12. PMID 9097883 DOI: 10.1177/026988119701100102 |
0.421 |
|
| 1997 |
Arranz MJ, Erdmann J, Kirov G, Rietschel M, Sodhi M, Albus M, Ball D, Maier W, Davies N, Franzek E, Abusaad I, Weigelt B, Murray R, Shimron-Abarbanell D, Kerwin R, et al. 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Neuroscience Letters. 224: 95-8. PMID 9086465 DOI: 10.1016/S0304-3940(97)13456-5 |
0.703 |
|
| 1997 |
Eastwood SL, Kerwin RW, Harrison PJ. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biological Psychiatry. 41: 636-43. PMID 9066986 DOI: 10.1016/S0006-3223(96)00220-X |
0.498 |
|
| 1997 |
Busatto GF, Pilowsky LS, Costa DC, Mertens J, Terriere D, Ell PJ, Mulligan R, Travis MJ, Leysen JE, Lui D, Gacinovic S, Waddington W, Lingford-Hughes A, Kerwin RW. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. European Journal of Nuclear Medicine. 24: 119-24. PMID 9021107 DOI: 10.1007/Bf00841413 |
0.301 |
|
| 1997 |
Gutiérrez B, Bertranpetit J, Guillamat R, Vallès V, Arranz MJ, Kerwin R, Fañanás L. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. The American Journal of Psychiatry. 154: 113-5. PMID 8988970 DOI: 10.1176/Ajp.154.1.113 |
0.543 |
|
| 1997 |
Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. The American Journal of Psychiatry. 154: 56-63. PMID 8988959 DOI: 10.1176/Ajp.154.1.56 |
0.381 |
|
| 1997 |
Travis MJ, Kerwin RW. Pharmacological Treatment of the Newly Diagnosed Patient with Schizophrenia Advances in Psychiatric Treatment. 3: 331-338. DOI: 10.1192/Apt.3.6.331 |
0.356 |
|
| 1997 |
Pilowsky LS, Mulligan RS, Acton PD, Gacinovic S, Busatto GF, Kessler RM, Ell PJ, Travis MG, Bigliani V, Stephenson C, Costa DC, Kerwin RW. 66. The effect of clozapine on extra-striatal dopamine D2 receptor binding in vivo: A 123I-epidepride SPET study Nuclear Medicine Communications. 18: 308. DOI: 10.1097/00006231-199704000-00068 |
0.33 |
|
| 1997 |
Polowsky L, Mulligan R, Acton P, Gacinovic S, Busatto G, Kessler R, Ell P, Travis M, Bigliani V, Stephenson C, Costa D, Kerwin R. Preliminary report: Effecrs of clozapine and typical antipsychotics on striataland limbic dopamine D2/D2-like receptors in vivo by 123I epidepride spet Schizophrenia Research. 24: 181. DOI: 10.1016/S0920-9964(97)82520-0 |
0.343 |
|
| 1997 |
Pilowsky L, O’Connell P, Davies N, Busatto G, Costa D, Ell P, Kerwin R. A 1231 IBZM spet study of striatal D2 receptors in sertindole treated patients Schizophrenia Research. 24: 180-181. DOI: 10.1016/S0920-9964(97)82519-4 |
0.327 |
|
| 1997 |
Busatto GF, Travis MJ, Pilowsky LS, Costa DC, Mulligan R, Mertens J, Terrière D, Ell PJ, Acton P, Gacinovic S, Okocha C, Leysen JE, Kerwin RW. 5-HT2A receptor blockade in vivo in schizophrenic patients treated with atypical antipsychotics: Single photon emission tomography (SPET) findings Schizophrenia Research. 24: 176-177. DOI: 10.1016/S0920-9964(97)82507-8 |
0.33 |
|
| 1997 |
Claire Royston M, Bell R, Collier D, Kerwin RW, Roberts GW. Apolipoprotein E and schizophrenia: Association with clinical response to clozapine Schizophrenia Research. 24: 93-94. DOI: 10.1016/S0920-9964(97)82255-4 |
0.373 |
|
| 1997 |
Bolonna A, Makoff A, Collier D, Kirov G, Munro J, Arranz M, Kerwin R. An investigation of the GLUR6 receptor gene (GRIK2) in schizophrenia Schizophrenia Research. 24: 93. DOI: 10.1016/S0920-9964(97)82252-9 |
0.439 |
|
| 1997 |
Sodhi MS, Kirov G, Aitchison KJ, Arranz MJ, Collier DA, Kerwin RW. Allelic variation of the 5-HT2C receptor in psychosis Schizophrenia Research. 24: 90-91. DOI: 10.1016/S0920-9964(97)82246-3 |
0.69 |
|
| 1997 |
Birkett JT, Collier DA, Munro J, Arranz MJ, Roberts GW, Price J, Kerwin RW. No association between a novel polymorphism in the 5-HT4 receptor gene and response to clozapine Schizophrenia Research. 24: 90. DOI: 10.1016/S0920-9964(97)82245-1 |
0.599 |
|
| 1997 |
Arranz M, Munro J, Sham P, Zhao J, Kirov G, Sodhi M, Spurlock G, Owen M, Collier D, Kerwin R. Polymorphisms in the 5-HT2A receptor gene and promoter region associated with clozapine response Schizophrenia Research. 24: 90. DOI: 10.1016/S0920-9964(97)82243-8 |
0.623 |
|
| 1997 |
Aitchison KJ, Munro J, Wright P, Chapman S, Collier DA, Kerwin RW. Pharmacogenetic factors in treatment-resistant schizophrenia: The role of CYP2D6 variants Schizophrenia Research. 24: 89. DOI: 10.1016/S0920-9964(97)82242-6 |
0.573 |
|
| 1997 |
Shaikh S, Collier D, Chioza B, Li T, Lui X, Kerwin R. A linkage disequilibrium study of chromosome 4p16 and schizophrenia Schizophrenia Research. 24: 53. DOI: 10.1016/S0920-9964(97)82150-0 |
0.336 |
|
| 1997 |
Cotter DR, Doshi B, Kerwin RW, Everall IP. Lateralised alterations in hippocampal MAP2 in schizophrenia Schizophrenia Research. 24: 32. DOI: 10.1016/S0920-9964(97)82089-0 |
0.334 |
|
| 1996 |
Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin RW. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters. 217: 177-8. PMID 8916101 DOI: 10.1016/0304-3940(96)13094-9 |
0.728 |
|
| 1996 |
Kerwin RW, Collier D. The dopamine D4 receptor in schizophrenia: an update. Psychological Medicine. 26: 221-7. PMID 8685278 DOI: 10.1017/S0033291700034619 |
0.415 |
|
| 1996 |
Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 97: 714-9. PMID 8641685 DOI: 10.1007/Bf02346178 |
0.642 |
|
| 1996 |
Kerwin R, Taylor DM. New antipsychotics: a review of their current status and clinical potential Cns Drugs. 6: 71-82. DOI: 10.2165/00023210-199606010-00006 |
0.422 |
|
| 1996 |
Sharma T, Kerwin R. Biological determinants of difficult to treat patients with schizophrenia. The British Journal of Psychiatry. Supplement. 169: 5-9. DOI: 10.1192/S0007125000298553 |
0.366 |
|
| 1996 |
Kerwin R, Collier D, Shaikh S, Arranz M. Pharmacological genetic association studies and clozapine response European Neuropsychopharmacology. 6: 25. DOI: 10.1016/0924-977X(96)87412-8 |
0.55 |
|
| 1996 |
Kerwin R, Aitchison K. Cost-effectiveness of treatments for schizophrenia European Neuropsychopharmacology. 6: S4-54. DOI: 10.1016/0924-977X(96)82924-5 |
0.517 |
|
| 1996 |
Pilowsky L, Busatto G, Costa D, Gacinovic S, Ell P, Kerwin R. In vivo receptor spet studies of antipsychotic drug action European Psychiatry. 11: 233s. DOI: 10.1016/0924-9338(96)88694-9 |
0.356 |
|
| 1996 |
Kerwin R. The 5HT2 receptor as a site for antipsychotics European Psychiatry. 11. DOI: 10.1016/0924-9338(96)88675-5 |
0.333 |
|
| 1996 |
Aitchison K, Kerwin R. The pharmaco-economics of schizophrenia: New horizons European Psychiatry. 11: 225s. DOI: 10.1016/0924-9338(96)88668-8 |
0.514 |
|
| 1996 |
Eastwood S, Porter R, Burnet P, Kerwin R, Harrison P. Non-NMDA glutamate receptor expression in schizophrenia Schizophrenia Research. 18: 174. DOI: 10.1016/0920-9964(96)85549-6 |
0.498 |
|
| 1996 |
Sodhi M, Arranz M, Ball D, Roberts G, Price J, Collier D, Kerwin R. Association between clozapine response and allelic variation in the 5-HT2A and 5-HT2C receptor genes Schizophrenia Research. 18: 165. DOI: 10.1016/0920-9964(96)85528-9 |
0.428 |
|
| 1996 |
Sodhi M, Kirov G, Arranz M, Ball D, Aitchison K, Kerwin R, Collier D. Association between psychoses and allelic variation in the 5-HT2C receptor gene Schizophrenia Research. 18: 164. DOI: 10.1016/0920-9964(96)85524-1 |
0.695 |
|
| 1996 |
Shaikh S, Collier D, Sham P, Aitchison K, Ball D, Gill M, Kerwin R. Allelic association between a ser-9-gly polymorphism in the D3 receptor gene and schizophrenia Schizophrenia Research. 18: 163. DOI: 10.1016/0920-9964(96)85520-4 |
0.642 |
|
| 1996 |
Aitchison K, Patel M, Taylor M, Murray R, Arranz M, Collier D, Kerwin R. Neuroleptic sensitivity and enzyme deficiency in two schizophrenic brothers: A case report Schizophrenia Research. 18: 152. DOI: 10.1016/0920-9964(96)85496-X |
0.485 |
|
| 1996 |
Sodhi MS, Arranz MJ, Kirov G, Ball DM, Aitchison KJ, Abusaad I, Kerwin RW, Collier DA. Association between psychoses and allelic variation in 5-HT2A and 5-HT2C receptor genes British Journal of Clinical Pharmacology. 41: 457P. |
0.684 |
|
| 1995 |
Shaikh S, Collier DA, Sham P, Pilowsky L, Sharma T, Lin LK, Crocq MA, Gill M, Kerwin R. Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients American Journal of Medical Genetics. 60: 541-545. PMID 8825892 DOI: 10.1002/Ajmg.1320600611 |
0.423 |
|
| 1995 |
Busatto GF, David AS, Costa DC, Ell PJ, Pilowsky LS, Lucey JV, Kerwin RW. Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography. Psychiatry Research. 61: 255-64. PMID 8748469 DOI: 10.1016/0925-4927(95)02750-R |
0.305 |
|
| 1995 |
Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, Collier DA, Kerwin RW. Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport. 7: 169-72. PMID 8742444 DOI: 10.1097/00001756-199512000-00041 |
0.742 |
|
| 1995 |
Arranz M, Sharma T, Sham P, Kerwin R, Nanko S, Owen M, Gill M, Collier D. Schizophrenia and the androgen receptor gene: report of a sibship showing co-segregation with Reifenstein syndrome but no evidence for linkage in 23 multiply affected families. American Journal of Medical Genetics. 60: 377-81. PMID 8546149 DOI: 10.1002/Ajmg.1320600506 |
0.595 |
|
| 1995 |
Gray NS, Pilowsky LS, Gray JA, Kerwin RW. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophrenia Research. 17: 95-107. PMID 8541255 DOI: 10.1016/0920-9964(95)00034-J |
0.385 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, Crocq MA, Gill M, Kerwin R, Collier DA. Cytochrome P4502D6 genotype does not determine response to clozapine. British Journal of Clinical Pharmacology. 39: 417-20. PMID 7640149 DOI: 10.1111/J.1365-2125.1995.Tb04471.X |
0.681 |
|
| 1995 |
Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 346: 281-2. PMID 7630250 DOI: 10.1016/S0140-6736(95)92168-0 |
0.724 |
|
| 1995 |
Curtis VA, Wright P, Reveley A, Kerwin R, Lucey JV. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. British Journal of Psychiatry. 166: 642-646. PMID 7620750 DOI: 10.1192/Bjp.166.5.642 |
0.368 |
|
| 1995 |
Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Research. Molecular Brain Research. 29: 211-23. PMID 7609609 DOI: 10.1016/0169-328X(94)00247-C |
0.467 |
|
| 1995 |
Curtis VA, Kerwin RW. A risk-benefit assessment of risperidone in schizophrenia. Drug Safety. 12: 139-45. PMID 7539272 DOI: 10.2165/00002018-199512020-00006 |
0.354 |
|
| 1995 |
Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. Psychopharmacology. 117: 55-61. PMID 7536945 DOI: 10.1007/Bf02245098 |
0.392 |
|
| 1995 |
Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Kerwin RW. GABAA receptor density and clinical dimensions of schizophrenia Nuclear Medicine Communications. 16: 216. DOI: 10.1097/00006231-199504000-00028 |
0.394 |
|
| 1995 |
Kerwin R, Pilowsky L, Busatto G, Costa D, Elf P. S-2-1 Imaging of neuroleptic occupancy in schizophrenia European Neuropsychopharmacology. 5: 164. DOI: 10.1016/0924-977X(95)90148-7 |
0.333 |
|
| 1995 |
Shaikh S, Kerwin R, Sham P, Sharma T, Collier D. D4 polymorphisms in schizophrenic patients treated with clozapine Schizophrenia Research. 15: 165-166. DOI: 10.1016/0920-9964(95)95514-A |
0.329 |
|
| 1995 |
Curtis V, Wright P, Reveley A, Kerwin R, Lucey J. Neuroendocrine evidence for serotonergic involvement in clinical response to clozapine Schizophrenia Research. 15: 147. DOI: 10.1016/0920-9964(95)95457-K |
0.303 |
|
| 1995 |
Aitchison K, Kerwin R. The costs and benefits of clozapine therapy in the UK Schizophrenia Research. 15: 141. DOI: 10.1016/0920-9964(95)95436-D |
0.411 |
|
| 1995 |
Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Kerwin RW. GABAA receptor changes in schizophrenia is assessed using 123I-iomazenil single photon emission tomography (SPET). A preliminary report Schizophrenia Research. 15: 78-79. DOI: 10.1016/0920-9964(95)95246-6 |
0.357 |
|
| 1995 |
Kerwin R, Harrison P. Loss of non nmda receptors in medial temporal lobe—-a robust neurochemical finding: autoradiographical, gene expression and immunocytochemical findings Schizophrenia Research. 15: 62. DOI: 10.1016/0920-9964(95)95196-G |
0.463 |
|
| 1995 |
Beckwith J, Stefanis N, McLaughlin D, Kerwin R. The expression of NMDA receptor subunits in schizophrenic post-mortem human hippocampus Schizophrenia Research. 15: 54. DOI: 10.1016/0920-9964(95)95171-5 |
0.302 |
|
| 1995 |
Beckwith J, McLaughlin D, Stefanis N, Eastwood S, Harrison P, Kerwin R. Expression of developmentally specific isoforms on non-NMDA mRNAs in the hippocampus of schizophrenics Schizophrenia Research. 15: 53-54. DOI: 10.1016/0920-9964(95)95170-E |
0.395 |
|
| 1995 |
Sodhi M, Arranz-Calderon M, Collier D, Kerwin R. The 5-HT 1C receptor gene and schizophrenia Schizophrenia Research. 15: 49-50. DOI: 10.1016/0920-9964(95)95159-7 |
0.627 |
|
| 1995 |
Shaikh S, Collier D, Arranz M, Crocq M, Gill M, Kerwin R. Examination of the DRD2 (SER-CYS) variant in schizophrenia Schizophrenia Research. 15: 48. DOI: 10.1016/0920-9964(95)95156-4 |
0.588 |
|
| 1995 |
Shaikh S, Collier D, Kerwin R. Homozygosity at the DRD3 does not influence response to clozapine Schizophrenia Research. 15: 48. DOI: 10.1016/0920-9964(95)95154-2 |
0.322 |
|
| 1995 |
Arranz M, Aitchison K, Kerwin R, Collier D. Analyses of clozapine response and the 5-HT2 gene Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95114-O |
0.547 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sharma T, Aitchison K, Crog MA, Gill M, Kerwin R, Collier DA. Cytochrome P450IID6 genotype does not determine response to clozapine Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95112-M |
0.558 |
|
| 1994 |
Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study. The British Journal of Psychiatry : the Journal of Mental Science. 164: 16-26. PMID 8137105 DOI: 10.1192/Bjp.164.1.16 |
0.361 |
|
| 1994 |
Pedro BM, Pilowsky LS, Costa DC, Hemsley DR, Ell PJ, Verhoeff NP, Kerwin RW, Gray NS. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia. Psychological Medicine. 24: 423-9. PMID 8084937 DOI: 10.1017/S0033291700027392 |
0.377 |
|
| 1994 |
Eastwood SL, Burnet PW, Beckwith J, Kerwin RW, Harrison PJ. AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. Neuroreport. 5: 1325-8. PMID 7919190 DOI: 10.1097/00001756-199406000-00007 |
0.429 |
|
| 1994 |
Kerwin R, Dumon V. Dopamine receptor genes and schizophrenia: the tail wags the dog? The Lancet. 343: 686. PMID 7907676 DOI: 10.1016/S0140-6736(94)91576-8 |
0.434 |
|
| 1994 |
Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW. 104. D2 dopamine receptor blockade with the atypical antipsychotics remoxipride and risperidone Nuclear Medicine Communications. 15: 254. DOI: 10.1097/00006231-199404000-00107 |
0.368 |
|
| 1994 |
Pilowsky L, Costa D, Ell P, Verhoeff N, Munray R, Kerwin R. In Vivo Studies of Dopamine D2 Receptor Binding in Schizophrenia by 1231 Iodobenzamide (IBZM) and Single Photon Emission Tomography (SPET) Clinical Science. 87: 43P-43P. DOI: 10.1042/Cs045043Pa_Pt2 |
0.376 |
|
| 1993 |
Kerwin R. In defence of clozapine. British Journal of Psychiatry. 162: 566-567. PMID 8481756 DOI: 10.1192/Bjp.162.4.566B |
0.362 |
|
| 1993 |
Pilowsky LS, Kerwin RW, Murray RM. Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 9: 83-91. PMID 8397727 DOI: 10.1038/Npp.1993.46 |
0.357 |
|
| 1993 |
Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study. Psychological Medicine. 23: 791-7. PMID 7901865 DOI: 10.1017/S0033291700025575 |
0.365 |
|
| 1993 |
Kerwin RW. Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. Psychological Medicine. 23: 547-51. PMID 7901861 DOI: 10.1017/S0033291700025319 |
0.398 |
|
| 1993 |
Busatto GF, Pilowsky LS, Ell PJ, Costa DC, Verhoeff NP, Kerwin RW. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone. The British Journal of Psychiatry : the Journal of Mental Science. 163: 833-4. PMID 7508329 DOI: 10.1192/Bjp.163.6.833 |
0.377 |
|
| 1993 |
Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW. 47. D2 dopamine receptor abnormalities in schizoprhenia Nuclear Medicine Communications. 14: 268. DOI: 10.1097/00006231-199304000-00049 |
0.336 |
|
| 1993 |
Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW. 45. D2 dopamine receptor blockade and response to anti-psychotic treatment Nuclear Medicine Communications. 14: 267. DOI: 10.1097/00006231-199304000-00047 |
0.363 |
|
| 1993 |
McLaughlin D, Beckwith J, Harrison P, Kerwin R. Expression of developmentally specific forms of glutamate receptor mRNAs in the hippocampus of schizophrenics Schizophrenia Research. 9: 223-224. DOI: 10.1016/0920-9964(93)90487-4 |
0.443 |
|
| 1993 |
Eastwood S, Falkai P, Bogerts B, Kerwin R, Harrison P. Hippocampal synaptophysin gene expression in schizophrenia Schizophrenia Research. 9: 217-218. DOI: 10.1016/0920-9964(93)90470-4 |
0.427 |
|
| 1993 |
Pilowsky L, Costa D, Ell P, Verhoeff N, Murray R, Kerwin R. Left lateralised asymmetry of striatal D2 receptor binding in antipsychotic free schizophrenic patients - A 123I IBZM spet study Schizophrenia Research. 9: 206-207. DOI: 10.1016/0920-9964(93)90440-T |
0.342 |
|
| 1993 |
Kerwin R, Pilowsky L, Costa D, Ell P, Murray R, Verhoeff N. D2 dopamine receptor occupancy and response to typical and atypical antipsychotics- A 123I IBZM SPET study Schizophrenia Research. 9: 200. DOI: 10.1016/0920-9964(93)90419-J |
0.383 |
|
| 1993 |
Busatto G, Costa D, Ell P, Pilowsky L, David A, Kerwin R. Activation studies of medial temporal and frontal lobes in schizophrenia: A study using 99mTc-HMPAO spet Schizophrenia Research. 9: 195. DOI: 10.1016/0920-9964(93)90405-8 |
0.339 |
|
| 1993 |
Shaikh S, Kerwin R, Collier D, Launer M, Pilowsky L, Munro J, Gill M. Functional D4 polymorphism in schizophrenics treated with clozapine Schizophrenia Research. 9: 123. DOI: 10.1016/0920-9964(93)90186-M |
0.321 |
|
| 1992 |
Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet. 340: 199-202. PMID 1353135 DOI: 10.1016/0140-6736(92)90467-H |
0.411 |
|
| 1992 |
Kerwin RW, Murray RM. A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophrenia Research. 7: 1-12. PMID 1350459 DOI: 10.1016/0920-9964(92)90067-F |
0.36 |
|
| 1991 |
Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet. 337: 450-2. PMID 1671470 DOI: 10.1016/0140-6736(91)93392-M |
0.471 |
|
| 1991 |
Pilowsky L, Costa D, Kerwin R, Murray R, Ell P. Central D2 dopaminergic receptor status in treatment responsive and treatment resistant schizophrenic patients as measured by 123I-IBZM single photon emission tomography (SPET) Schizophrenia Research. 4: 410. DOI: 10.1016/0920-9964(91)90363-V |
0.311 |
|
| 1990 |
Kerwin RW, Beats BC. Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography. Neuroscience Letters. 118: 164-8. PMID 2274265 DOI: 10.1016/0304-3940(90)90617-I |
0.313 |
|
| 1989 |
Kerwin R, Burnett F. Schizophrenia induced by restitution of thyroid function in a predisposed patient. The Lancet. 334: 339. PMID 2569144 DOI: 10.1016/S0140-6736(89)90529-1 |
0.335 |
|
| 1988 |
Kerwin RW. Pathology, phenomenology, and the dopamine hypothesis of schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 152: 141-2. PMID 3167325 DOI: 10.1192/S0007125000137821 |
0.374 |
|
| 1988 |
Murray RM, Kerwin RW. Neurodevelopmental Model of Schizophrenia Archives of General Psychiatry. 45: 1052-1053. DOI: 10.1001/Archpsyc.1988.01800350086015 |
0.36 |
|
| 1981 |
Pycock CJ, Kerwin RW. The status of glycine as a supraspinal neurotransmitter. Life Sciences. 28: 2679-86. PMID 6115295 DOI: 10.1016/0024-3205(81)90168-5 |
0.506 |
|
| 1981 |
Pycock CJ, Dawbarn D, Kerwin RW. Roles of GABA and glycine in the substantia nigra. Advances in Biochemical Psychopharmacology. 29: 77-87. PMID 6114627 |
0.485 |
|
| 1980 |
Cox B, Kerwin RW, Lee TF, Pycock CJ. A dopamine-5-hydroxytryptamine link in the hypothalamic pathways which mediate heat loss in the rat. The Journal of Physiology. 303: 9-21. PMID 7431248 |
0.549 |
|
| 1980 |
Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 286: 74-6. PMID 7393327 |
0.546 |
|
| 1980 |
Cox B, Kerwin RW, Lee TF, Pycock CJ. Evidence in vivo for a 5-hydroxytryptamine link in dopamine-receptor-mediated hypothermia in the rat [proceedings]. British Journal of Pharmacology. 68: 168P-169P. PMID 7357182 |
0.567 |
|
| 1980 |
Kerwin RW, Luscombe GP, Pycock CJ, Sverakova K. Behavioural and biochemical studies in rats with N-methyl-D-aspartic acid and kainic acid [proceedings]. British Journal of Pharmacology. 68: 174P-175P. PMID 6986937 |
0.492 |
|
| 1980 |
Cox B, Kerwin RW, Lee TF, Pay S, Pycock CJ. Evidence in vitro for a 5-HT link in dopaminergic neurotransmission in the anterior hypothalamic region of the rat: demonstration of a 5-HT link in dopaminergic thermoregulation? [proceedings]. British Journal of Pharmacology. 68: 162P. PMID 6244028 |
0.526 |
|
| 1980 |
Pycock CJ, Carter CJ, Kerwin RW. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. Journal of Neurochemistry. 34: 91-9. PMID 6161214 |
0.515 |
|
| 1980 |
Kerwin RW, Pay S, Bhoola KD, Pycock CJ. Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons. The Journal of Pharmacy and Pharmacology. 32: 561-6. PMID 6106694 |
0.506 |
|
| 1980 |
Kerwin RW, Pycock CJ. GABA inhibition of glycine release from rat substantia nigra Neuroscience Letters. 19: S269. |
0.488 |
|
| 1980 |
Carter CJ, Kerwin RW, Pycock CJ. Indication of subcortical dopamine receptor sensitivity following destruction of frontal cortical dopamine terminals Journal of Physiology. 51P-52P. |
0.555 |
|
| 1980 |
Kerwin RW, Pycock CJ. The action of adenosine on [3H]-neurotransmitter release from rat striatal slices in vitro British Journal of Pharmacology. 70: 136p-137p. |
0.496 |
|
| 1979 |
Kerwin RW, Carter C, Pycock C. A comparison of l- and d-baclofen on dopamine dependent behaviour in the rat. Neuropharmacology. 18: 655-9. PMID 573872 DOI: 10.1016/0028-3908(79)90031-5 |
0.518 |
|
| 1979 |
Kerwin RW, Pycock CJ. A comparison of the effects of GABA and glycine on the release of [3H]-dopamine from rat striatal slices [proceedings]. British Journal of Pharmacology. 66: 106P. PMID 454901 |
0.518 |
|
| 1979 |
Kerwin RW, Pycock CJ. Specific stimulating effect of glycine on 3H-dopamine efflux from substantia nigra slices of the rat. European Journal of Pharmacology. 54: 93-8. PMID 421746 DOI: 10.1016/0014-2999(79)90411-4 |
0.529 |
|
| 1979 |
Kerwin RW, Pycock CJ. Thyrotrophin releasing hormone stimulates release of [3H]-dopamine from slices of rat nucleus accumbens in vitro. British Journal of Pharmacology. 67: 323-5. PMID 115532 |
0.518 |
|
| 1979 |
Kerwin RW, Pycock CJ. Interactions of putative neurotransmitters in the region of the raphé nuclei of the rat [proceedings]. British Journal of Pharmacology. 66: 477P. PMID 43180 |
0.49 |
|
| 1979 |
Kerwin RW, Pycock CJ. The effect of some putative neurotransmitters on the release of 5-hydroxytryptamine and gamma-aminobutyric acid from slices of the rat midbrain raphe area. Neuroscience. 4: 1359-65. PMID 40162 DOI: 10.1016/0306-4522(79)90163-5 |
0.502 |
|
| 1979 |
Kerwin RW, Pycock CJ. Role of taurine as a possible transmitter in the thermoregulatory pathways of the rat. The Journal of Pharmacy and Pharmacology. 31: 466-70. PMID 38317 |
0.499 |
|
| 1979 |
Pycock CJ, Carter CJ, Kerwin RW. Possible involvement of frontal-cortical catecholamine systems in the regulation of neurotransmitter mechanisms at sub-cortical sites in the rat brain [proceedings]. Biochemical Society Transactions. 7: 140-3. PMID 35418 |
0.492 |
|
| 1978 |
Kerwin R, Pycock C. Baclofen (beta-p-chlorophenyl-gamma-aminobutyric acid) enhances [3H]gamma-aminobutyric acid (3H-GABA) release from rat globus pallidus in vitro. The Journal of Pharmacy and Pharmacology. 30: 622-7. PMID 30815 DOI: 10.1111/j.2042-7158.1978.tb13343.x |
0.503 |
|
| Show low-probability matches. |